P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID-19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS
Main Authors: | , , , , , , , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Wiley
2023-08-01
|
丛编: | HemaSphere |
在线阅读: | http://journals.lww.com/10.1097/01.HS9.0000973128.79769.f1 |